Keen Eye Company Profile

00:57 EST 21st January 2019 | BioPortfolio

News Articles [34 Associated News Articles listed on BioPortfolio]

Keen Eye, Iris Pharma partner to bring AI in ophthalmology studies

The partnership intends to offer Iris Pharma AI applications to make assays faster, more reliable and more efficient. Keen Eye’s advanced AI technology allows Iris Pharma to optimize the The p...

Deals this week: Sitryx, Keen Eye, Accera

Sitryx has raised $30m in a Series A financing round led by SV Health Investors and Sofinnova Partners. The funds...Read More... The post Deals this week: Sitryx, Keen Eye, Accera appeared first on Dr...

Investors keen to put money into AMR SMEs

UK to unveil £1bn life sciences investment

Government keen to show Britain remains attractive despite Brexit

Keen Eye and Iris Pharma Team up to Bring Artificial Intelligence in Ophthalmology Studies

Keen Eye, a French technology company specialized in image analysis for the life science industry, announced today a strategic partnership agreement with

For CDMOs, continuous manufacturing isn't an 'if,' but a 'how'

Contract services providers are receiving more interest from drugmakers keen on the technology's potential cost-savings and better efficiency.

Editorial: Airlines are among the companies keen on converting biomass to liquid fuel. An update of century-old chemical reaction could produce kerosene from biomass 

Editorial: Airlines are among the companies keen on converting biomass to liquid fuel. An update of century-old chemical reaction could produce kerosene from biomass

US FDA to make decision on Shield Therapeutics’ Feraccru drug by end of July

The US is a huge and potentially lucrative market that Shield is understandably keen to crack

PubMed Articles [16 Associated PubMed Articles listed on BioPortfolio]

Recent advances of on-demand dissolution of hydrogel dressings.

Wound management is a major global challenge and a big financial burden to the healthcare system due to the rapid growth of chronic diseases including the diabetes, obesity, and aging population. Mode...

Reply by Bell et al.

We thank Sood and colleagues for their keen interest in our study. They make a valid point, and suggest that BMI is an imprecise predictor of surgical challenges (which we agree with), however the rat...

The surgeon in action: representations of neurosurgery in movies from the frères lumière to today.

In this review we examine the portrayal of neurosurgery and neurosurgeons in 61 movies produced from the beginnings of cinema from the Lumière brothers (1895) to 2017, across four continents and cove...

Visual intelligence education as an innovative interdisciplinary approach for advancing communication and collaboration skills in nursing practice.

Recognizing the relationship of keen observation to communication, critical thinking, and leadership in evidence-based literature, educators have expanded the use of art museums to augment visual inte...

Cost and Complications Are Limitations In Resource-Constrained Settings For Equine Anti-Thymocyte Globulin.

We read with keen interest the article written by Krista Vaht et al. (1) about the low response rate to ATG-based immunotherapy in very severe aplastic anemia. The article nicely describes the real w...

Clinical Trials [7 Associated Clinical Trials listed on BioPortfolio]

Blueberry Consumption and Type 2 Diabetes

Lifestyle strategies that include dietary modification, such as consumption of a plant-based diet, are well recognized in disease prevention and may improve type 2 diabetes. Various compon...

The Effect of Intermittent Energy Restriction Using Meal Replacements in Overweight Chinese Subjects

Background and Aims: The "5:2 diet", a form of intermittent energy restriction, has been popularized in Europe and USA. The rationale behind this approach is that two days of dieting is po...

iCST Web-application for People With Dementia

In the UK, over 670,000 older people are living with dementia which has a substantial, multi-level impact on society, the person with dementia, and their carers. There is a need for an inc...

Pirfenidone for Restrictive Chronic Lung Allograft Dysfunction

Despite advances in lung transplantation, the median survival remains only 55% at 5 years. The main limitation to long term survival is the development of chronic lung allograft dysfunctio...

Innovation Adoption in Medical Robotic Surgery: Case of Royal Bournemouth Hospital

This research sets to address two key areas. The first is identified by the researcher in academic literature that there is a lack of a comprehensive innovation adoption model in UK Nation...

Companies [29 Associated Companies listed on BioPortfolio]

Keen-Summit Capital Partners

Keen-Summit Capital Partners LLC, located in New York, provides real estate analysis, valuation and strategic planning services, brokerage, M&A, auction services, lease restructur...


KEEN Inc., manufacturer of hybrid footwear, socks and bags, is an outdoor brand that delivers innovative hybrid products, enabling outdoor enthusiasts to live active lifest...

Keen Eye

Rebecca Wang

Rebecca Wang is an entrepreneur, executive film producer and former psychotherapist who is passionate about all forms of artistic expression. She is also keen in her desire to bri...

Beacon Bioscience, Inc

Beacon Bioscience, the Medical Imaging CRO provides phase I - IV integrated imaging solutions - from protocol design to regulatory submission - for pharmaceutical and biotech clients around the globe....

More Information about "Keen Eye" on BioPortfolio

We have published hundreds of Keen Eye news stories on BioPortfolio along with dozens of Keen Eye Clinical Trials and PubMed Articles about Keen Eye for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Keen Eye Companies in our database. You can also find out about relevant Keen Eye Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record